Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Biomarkers in Alzheimer's disease: past, present and future.

Gustaw-Rothenberg K, Lerner A, Bonda DJ, Lee HG, Zhu X, Perry G, Smith MA.

Biomark Med. 2010 Feb;4(1):15-26. Review.

2.

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.

Hampel H, Mitchell A, Blennow K, Frank RA, Brettschneider S, Weller L, Möller HJ.

J Neural Transm (Vienna). 2004 Mar;111(3):247-72. Epub 2003 Dec 3. Review.

PMID:
14991453
3.

Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.

Prvulovic D, Hampel H.

Clin Chem Lab Med. 2011 Mar;49(3):367-74. doi: 10.1515/CCLM.2011.087. Epub 2011 Feb 23. Review.

PMID:
21342022
4.

Genetic and biochemical markers for Alzheimer's disease: recent developments.

Mulder C, Scheltens P, Visser JJ, van Kamp GJ, Schutgens RB.

Ann Clin Biochem. 2000 Sep;37 ( Pt 5):593-607. Review. No abstract available.

PMID:
11026514
5.

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2010 May;6(3):230-8. doi: 10.1016/j.jalz.2010.03.008. Review.

8.

Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.

Weise D, Tiepolt S, Awissus C, Hoffmann KT, Lobsien D, Kaiser T, Barthel H, Sabri O, Gertz HJ.

J Alzheimers Dis. 2015;48(2):425-32. doi: 10.3233/JAD-150229.

PMID:
26402006
9.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
10.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
11.

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.

Wallin AK, Blennow K, Andreasen N, Minthon L.

Dement Geriatr Cogn Disord. 2006;21(3):131-8. Epub 2006 Jan 2.

PMID:
16391474
12.

Alzheimer's disease.

Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM.

Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24. Review.

PMID:
26921134
13.

Combined assessment of serum folate and hemoglobin as biomarkers of brain amyloid β accumulation.

Yoshinaga T, Nishimata H, Kajiya Y, Yokoyama S.

PLoS One. 2017 Apr 13;12(4):e0175854. doi: 10.1371/journal.pone.0175854. eCollection 2017.

14.

Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.

Di Domenico F, Pupo G, Giraldo E, Badìa MC, Monllor P, Lloret A, Schininà ME, Giorgi A, Cini C, Tramutola A, Butterfield DA, Viña J, Perluigi M.

Free Radic Biol Med. 2016 Feb;91:1-9. doi: 10.1016/j.freeradbiomed.2015.12.004. Epub 2015 Dec 8.

PMID:
26675344
15.

Biomarker modeling of Alzheimer's disease.

Jack CR Jr, Holtzman DM.

Neuron. 2013 Dec 18;80(6):1347-58. doi: 10.1016/j.neuron.2013.12.003. Review.

16.

Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.

Oláh Z, Kálmán J, Tóth ME, Zvara Á, Sántha M, Ivitz E, Janka Z, Pákáski M.

J Alzheimers Dis. 2015;44(4):1303-12. doi: 10.3233/JAD-140141.

PMID:
25428253
17.

Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.

Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.

J Alzheimers Dis. 2010;22(4):1363-73. doi: 10.3233/JAD-2010-101368.

PMID:
20930272
18.

Alzheimer's disease and the quest for its biological measures.

Praticò D.

J Alzheimers Dis. 2013;33 Suppl 1:S237-41. doi: 10.3233/JAD-2012-129023. Review.

PMID:
22695619
19.

[Development of Disease-modifying Therapy for Alzheimer's Disease].

Akiyama H.

Brain Nerve. 2016 Apr;68(4):463-72. doi: 10.11477/mf.1416200419. Review. Japanese.

PMID:
27056864
20.

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

Wang T, Xiao S, Liu Y, Lin Z, Su N, Li X, Li G, Zhang M, Fang Y.

Int J Geriatr Psychiatry. 2014 Jul;29(7):713-9. doi: 10.1002/gps.4053. Epub 2013 Dec 7.

PMID:
24318929

Supplemental Content

Support Center